SEC Form 4 · accession 0001104659-17-008172
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Paul
Officer — President and CEO · Director
Period of report
Feb 8, 2017
Accepted (ET)
Feb 10, 2017 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.83 | Feb 8, 2017 | A | 240,000 | A | — | Feb 8, 2027 | Common Stock | 240,000 | 240,000 | D |
Explanation of responses
- F1This stock option award was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan and will vest in 48 equal monthly installments from grant date.